MedPath

The effect of intermittent fasting diet on fatty liver

Phase 1
Conditions
fatty liver.
Fatty (change of) liver, not elsewhere classified
K76.0
Registration Number
IRCT20170202032367N5
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
52
Inclusion Criteria

Age 50-20 years
Body mass index 25 - 30 kg/m2
Both genders
Diagnosis of osteohepatitis based on Cap-score> 263
subjects with hepatic fibrosis based on Metavir-score = F2
Willingness to cooperate

Exclusion Criteria

Consumption of alcohol
Other acute and chronic liver diseases
Autoimmune diseases, kidney diseases, biliary diseases, diabetes, cancer
Pregnancy and lactation
Use of hepatotoxic drugs (phenytoin, lithium, tamoxifen, antibiotics), weight loss drugs, sage and corticosteroids
Follow a special diet in the last three months

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath